Bartronics India Limited has entered into a strategic partnership with Bank of Maharashtra, signing a Service Level Agreement (SLA) to serve as a Corporate Business Correspondent (CBC) under the bank's Financial Inclusion Programme. This collaboration, formalized on November 4, 2025, aims to expand banking services to underserved areas across India.

Key Partnership Details

Scope of Services

Bartronics India Limited will provide:

1. Customer service points
2. Technology infrastructure
3. Operational support for banking services

These services will be implemented in:

• Unbanked areas
• Rural locations
• Semi-urban areas
• Urban centers
• Metro locations

Implementation Strategy

Bartronics plans to establish:

• Biometric-supported kiosks
• Non-kiosk outlets

These facilities aim to deliver banking services to individuals with limited access to traditional banking infrastructure.

Significance of the Partnership

This collaboration is part of Bank of Maharashtra's Financial Inclusion Programme, designed to extend banking services to underserved populations. By leveraging Bartronics' technological capabilities and operational expertise, the bank aims to create more accessible touch points for customers across diverse geographical locations.

The partnership aligns with broader national initiatives to increase financial inclusion and bring formal banking services to previously unbanked or underbanked segments of the population.

Regulatory Compliance

As per the disclosure made under Schedule III (Part A) of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bartronics India Limited has confirmed that this agreement is in the ordinary course of business and does not constitute a related party transaction.

This strategic alliance between Bartronics India Limited and Bank of Maharashtra represents a significant step towards enhancing financial accessibility across India, potentially transforming the banking landscape in underserved areas.

Bartronics India Limited (BIL) has announced a strategic investment of up to ₹50 crore in Huwel Life Sciences Pvt. Ltd, a Hyderabad-based molecular diagnostics innovator. This move marks a significant step towards advancing affordable diagnostics in India and global health markets.

Key Highlights of the Partnership

• BIL will acquire a 15% equity stake in Huwel Life Sciences, with an option to increase it by an additional 15%.
• The collaboration aims to combine BIL's scaling expertise with Huwel's innovation capabilities.
• Huwel Life Sciences, led by Dr. Rachana Tripathi, has developed over 100 validated diagnostic products across various diseases.
• The partnership focuses on expanding market reach, technology support, and securing government and international orders.

Huwel Life Sciences: A Leader in Diagnostic Innovation

Huwel Life Sciences, operating from an ISO-certified, CE/FDA-compliant facility in Hyderabad, has made significant strides in the field of diagnostics:

• Developed more than 100 validated diagnostic products for TB, infectious diseases, cancer, and more.
• Played a crucial role during the COVID-19 pandemic by delivering RT-PCR solutions at scale.
• Secured grants from the Bill & Melinda Gates Foundation and received orders from the World Health Organization.

Flagship Product: Quantiplus® TB Fast Detection Kit

The partnership's cornerstone is Huwel's breakthrough low-cost TB solution:

• Quantiplus® TB Fast Detection Kit is approved by ICMR and launched by the Union Health Minister.
• It's the only open-system, affordable RT-PCR solution for TB confirmatory testing in India.
• Aligns with the National TB Elimination Programme (NTEP) and the vision of a 'TB Mukt Bharat'.

Bartronics India's Role and Benefits

Under this strategic partnership, Bartronics India will:

• Drive market growth and deliver technology support.
• Manage digital outreach and develop customized applications and platforms.
• Lead in identifying opportunities, negotiating commercial terms, and securing orders.
• Benefit from assured revenue through a designated subsidiary managing business execution.

Future Outlook

Mr. Vidhya Sagar Reddy, Managing Director of Bartronics India Limited, emphasized the partnership's potential: "It is about building a monopoly-strength product portfolio from India for the world. It also strengthens our role in national health programs while creating recurring revenue opportunities."

Dr. Rachana Tripathi, CEO of Huwel Life Sciences, added: "With our ICMR-certified TB solution and expanding product portfolio—and with BIL's partnership, we are ready to scale across India and globally."

The collaboration between Bartronics India and Huwel Life Sciences aims to:

• Strengthen India's healthcare system
• Accelerate disease elimination programs
• Establish global leadership in affordable diagnostics
• Expand into emerging markets in Africa and Southeast Asia

This partnership represents a significant step towards positioning India as a global hub for life sciences innovation and manufacturing, promising a healthier future for India and the world.